Nashton Partners II Custom Case Solution & Analysis

1. Evidence Brief: Nashton Partners II

Financial Metrics

• Revenue Growth: Increased from 6.5 million in 2011 to 32.2 million in 2016.
• EBITDA Performance: Grew from 1.6 million to 8.1 million over the same five-year period.
• Compound Annual Growth Rate (CAGR): Revenue grew at approximately 38 percent annually.
• Margin Profile: Maintained consistent EBITDA margins exceeding 25 percent.
• Capital Expenditures: Low intensity, primarily focused on specialized spray equipment and vehicle fleets.
• Exit Valuation: Strategic interest from Rentokil Initial suggests a multiple significantly higher than the 4.5x entry multiple paid in 2011.

Operational Facts

• Service Model: Vector Disease Control International (VDCI) specializes in mosquito control services for municipal and county governments.
• Geographic Footprint: Expanded from a regional player to a national presence across the United States through organic growth and strategic acquisitions.
• Revenue Mix: Split between recurring municipal contracts and lumpy, high-margin emergency response work triggered by disease outbreaks like West Nile or Zika.
• Human Capital: High reliance on specialized entomologists and pilots for aerial application.
• Regulatory Environment: Operations governed by strict EPA guidelines and local health department oversight.

Stakeholder Positions

• Jason Pananos and Jay Davis: Managing Partners of Nashton Partners. Their search fund model reached the typical five-to-seven-year exit window. They prioritize a clean handoff that protects the brand legacy.
• Daniel Markowski: Key technical leader and entomologist whose retention is vital for operational continuity.
• Rentokil Initial: The prospective buyer seeking to enter the specialized North American government services niche.
• Search Fund Investors: Seeking liquidity and a high internal rate of return (IRR) to validate the search fund asset class.

Information Gaps

• Specific retention terms for middle management during the Rentokil transition.
• The exact percentage of revenue derived from emergency response versus multi-year recurring contracts in the 2016 fiscal year.
• Detailed breakdown of the 2017 pipeline and projected impact of diminishing Zika virus concerns on emergency revenue.

2. Strategic Analysis

Core Strategic Question

• Should Nashton Partners continue to scale VDCI as an independent platform through further acquisitions, or is the current valuation premium offered by a strategic buyer like Rentokil the peak of the cycle?

Structural Analysis

The vector control industry exhibits high barriers to entry due to specialized technical requirements and long-standing government relationships. However, the bargaining power of buyers is significant as municipal budgets are subject to political shifts. The industry is currently in a consolidation phase. Rentokil possesses a global infrastructure that can absorb VDCI to achieve cost efficiencies in procurement and fleet management that a stand-alone search fund cannot match. The value chain analysis indicates that the highest margins reside in the technical expertise and aerial capabilities, which VDCI has successfully institutionalized.

Strategic Options

• Option 1: Exit to Strategic Buyer (Rentokil). This path secures a high IRR for investors and transfers operational risk to a global entity. It acknowledges that VDCI has reached a size where further growth requires a different capital structure.
• Option 2: Continued Consolidation (Roll-up). Nashton could acquire 2-3 smaller regional players. This increases scale but raises integration risk and delays liquidity for original search fund investors.
• Option 3: Diversification into Commercial Pest Control. Moving into non-government sectors would reduce reliance on municipal budgets but would place VDCI in direct competition with established giants like Terminix and Orkin in a crowded market.

Preliminary Recommendation

Execute the sale to Rentokil. The 2016 financial performance was bolstered by emergency response revenue which is inherently volatile. Selling on the heels of these results allows Nashton to capture a valuation based on peak earnings that may not be sustainable if the next three years are quiet from a public health perspective.

3. Implementation Roadmap

Critical Path

• Month 1: Finalize the Quality of Earnings report to validate the 8.1 million EBITDA, specifically separating recurring from emergency revenue.
• Month 2: Secure employment agreements for the top five technical leads, including Daniel Markowski, to ensure value preservation for the buyer.
• Month 3: Conduct a comprehensive audit of all municipal contracts to ensure assignability clauses do not trigger re-bidding upon change of control.
• Month 4: Execute the definitive purchase agreement and announce the transition to the employee base.

Key Constraints

• Talent Retention: The business is built on technical credibility. The loss of key entomologists during the sale process would devalue the asset.
• Contract Assignability: If major county contracts require a full re-tender due to the ownership change, the revenue stability is compromised.

Risk-Adjusted Implementation Strategy

The plan assumes a 120-day closing window. To mitigate the risk of deal fatigue or price renegotiation, Nashton must maintain a parallel track of operational improvements. This ensures that if the Rentokil deal fails, the business remains optimized for a secondary auction or continued hold. Contingency includes a 10 percent holdback of the purchase price to cover potential indemnification claims related to environmental compliance.

4. Executive Review and BLUF

BLUF

Sell VDCI to Rentokil immediately. Nashton Partners has successfully transformed a founder-led business into a professionalized national platform. With 32.2 million in revenue and 25 percent margins, the company has reached the point of diminishing returns for the search fund model. The current valuation is inflated by recent emergency response demand that is non-recurring. Delaying the exit exposes investors to downside risk from municipal budget cuts or a decline in public health crises. The math dictates an exit while the EBITDA profile is at its historical zenith.

Dangerous Assumption

The analysis assumes that Rentokil will value the emergency response revenue at the same multiple as the recurring municipal revenue. If the buyer applies a significant discount to the lumpy portion of the earnings, the expected exit price may drop by 15-20 percent.

Unaddressed Risks

• Regulatory Shift: Increased environmental restrictions on aerial spraying could overnight render the core service delivery model obsolete or significantly more expensive.
• Concentration Risk: While national, a significant portion of revenue remains tied to a few large county contracts. The loss of one major account during the due diligence phase would jeopardize the entire transaction.

Unconsidered Alternative

The team did not fully explore a recapitalization. By bringing in a mid-market private equity firm, Pananos and Davis could take chips off the table while retaining an equity stake to participate in a second, larger exit after another five years of consolidation. This would solve the liquidity need while capturing future upside.

Verdict: APPROVED FOR LEADERSHIP REVIEW